Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/10/2010US20100144622 Methods for production of recombinant plasminogen and plasmin polypeptides
06/10/2010US20100144621 Use of Exendins and Exendin Agonists and GLP-1 Receptor Agonists for Altering the Concentration of Fibrinogen
06/10/2010US20100144620 Complementation of factor xi deficeincy by factor v mutants
06/10/2010US20100144619 Antimicrobial Protein Specific to Staphylococcus Aureus
06/10/2010US20100144618 Compositions containing an intestinal trefoil peptide and a mucoadhesive
06/10/2010US20100144617 Oxyntomodulin Derivatives
06/10/2010US20100144616 Neuroprotective methods and reagents
06/10/2010US20100144615 Nucleotide sequence encoding a modulator of nf-kb
06/10/2010US20100144614 Altering memory by affecting staufen function
06/10/2010US20100144613 Combined use of DPP-IV Inhibitors and Gastrin Compounds
06/10/2010US20100144612 Phosphorylated pyrone analogs and methods
06/10/2010US20100144611 Treatment of t-cell mediated diseases
06/10/2010US20100144610 Pharmaceutical formulations
06/10/2010US20100144609 Methods using cyclosporin in treating patients with intraocular lenses
06/10/2010US20100144608 Macrocyclic hepatitis C serine protease inhibitors
06/10/2010US20100144607 Anti-inflammatory and antiallergic cyclic peptides
06/10/2010US20100144606 Combination 408
06/10/2010US20100144605 Rescue of gonadotropin releasing hormone receptor mutants
06/10/2010US20100144604 Novel cellular factor-containing solution compositions
06/10/2010US20100144603 Methods and uses thereof of prosaposin
06/10/2010US20100144602 Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
06/10/2010US20100144601 Anti-TNF Alpha Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses
06/10/2010US20100144600 Osteoprotegerin variant proteins
06/10/2010US20100144599 Vegf pathway blockade
06/10/2010US20100144598 Natural Polypeptides For Oral Health Care
06/10/2010US20100144597 Novel combinatorial approaches to enhancing oxygen transport to tissues
06/10/2010US20100144596 An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof
06/10/2010US20100144595 Lyophilization of Hemoglobin Solutions
06/10/2010US20100144594 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors
06/10/2010US20100144593 Pharmaceutical Compositions and Methods for Insulin Treatment
06/10/2010US20100144592 Stable Non-Aqueous Pharmaceutical Compositions
06/10/2010US20100144591 Benzimidazole derivatives and methods of use thereof
06/10/2010US20100144589 Methods of predicting cancer lethality using replikin counts
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010US20100144587 Frequency modulated drug delivery (FMDD)
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/10/2010US20100144039 Pluripotency determining factors and uses thereof
06/10/2010US20100144026 siRNA-mediated gene silencing with viral vectors
06/10/2010US20100144012 A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y; for genome engineering and gene therapy
06/10/2010US20100143973 Interleukin-11 Fusion Proteins
06/10/2010US20100143504 Compositions and methods for cardiac tissue protection and regeneration
06/10/2010US20100143490 Composite material
06/10/2010US20100143485 Oxycontin controlled release formulations and methods of using same
06/10/2010US20100143484 Oral submicron particle delivery system for proteins and process for its production
06/10/2010US20100143477 Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof
06/10/2010US20100143473 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
06/10/2010US20100143458 Glutamic acid decarboxylase (gad) based delivery system
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143444 Peptides and peptide mimetics to treat pathologies associated with eye disease
06/10/2010US20100143442 Growth factor complexes and modulation of cell migration and growth
06/10/2010US20100143441 Nortriptyline compounds for promoting bone growth
06/10/2010US20100143440 Ul97 inhibitors for treatment of proliferative disorders
06/10/2010US20100143439 Hybrid Biomimetic Particles, Methods of Making Same and Uses Therefor
06/10/2010US20100143438 Biomolecules
06/10/2010US20100143436 Self-assembly of protein-based biomaterials with multiple morphologies
06/10/2010US20100143434 Mechanically responsive supported polyelectrolyte multilayer films
06/10/2010US20100143433 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
06/10/2010US20100143424 Casein nanoparticle
06/10/2010US20100143420 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability
06/10/2010US20100143416 Alpha-defensins as anthrax immunotherapeutis
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143386 FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100143382 Modulation of rhamm (cd168) for selective adipose tissue development
06/10/2010US20100143381 Lysophosphatidic acid receptor targeting for lung disease
06/10/2010US20100143379 Mif agonists and antagonist and therapeutic uses thereof
06/10/2010US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143357 Uses of Mammalian Cytokine; Related Reagents
06/10/2010US20100143352 Combination therapy for b cell disorders
06/10/2010US20100143346 Treatment of Macular Degeneration
06/10/2010US20100143344 Complement inhibition for improved nerve regeneration
06/10/2010US20100143341 Thienopyrimidines for pharmaceutical compositions
06/10/2010US20100143338 Treatment of t-cell mediated diseases
06/10/2010US20100143335 Treating atherosclerosis
06/10/2010US20100143333 Method of treating diabetes
06/10/2010US20100143330 Methods of treating disorders associated with fat storage
06/10/2010US20100143328 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
06/10/2010US20100143327 Injection of fibrin sealant including an anesthetic in spinal applications
06/10/2010US20100143326 SUBCUTANEOUS ADMINISTRATION OF COAGULATION FACTOR VIIa-RELATED POLYPEPTIDES
06/10/2010US20100143325 Composition And Methods Involving Thrombolytic Agents
06/10/2010US20100143324 Method for treatment of cancers or inflammatory diseases
06/10/2010US20100143323 Modified phosphatases
06/10/2010US20100143322 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
06/10/2010US20100143321 Therapeutic composition for interstitual pneumonia
06/10/2010US20100143320 Dietary supplement
06/10/2010US20100143319 Kiwifruit compositions
06/10/2010US20100143318 Gstp1 as teratogenic allele for autism and assays and methods based thereon
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143309 Viral vectors
06/10/2010US20100143301 Modulators of toll-like receptors
06/10/2010US20100143300 Hepatitis c therapies
06/10/2010US20100143299 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
06/10/2010US20100143298 Colloidal metal compositions and methods
1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 3163